T1	Participants 515 607	Patients with invasive breast cancer were enrolled in the INTENS study between 2006 and 2009
T2	Participants 621 734	182 patients, of whom data were available for post-NAC MRI (n=155), US (n=123), and histopathological tumour size
T3	Participants 87 133	post-neoadjuvant chemotherapy in breast cancer
